Palmitoylethanolamide | Interleukin Related interleukin-related.com

Product Name :
Palmitoylethanolamide

Search keywords :
Palmitoylethanolamide

drugId :
null

Target Vo:
Cannabinoid receptor

Target Vo Short Name :
CB

Moa_Name:
Cannabinoid receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Epitech Group

Active Company_Name :
Brigham and Women’s Hospital Inc

Active Indication_Name:
Dermatitis, Atopic

In Active Indication_Name:
Mastocytosis

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MEK1 Antibody
Phospho-IGF1 Receptor (Tyr1166) Antibody
Integrin beta 3 Antibody: Integrin beta 3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 87 kDa, targeting to Integrin beta 3. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts